Omron Healthcare, Dr. Oz team up to underscore home blood-pressure monitoring
BANNOCKBURN, Ill. Omron Healthcare has joined forces with "The Dr. Oz Show" in an integrated media partnership to help spread the word about the importance of home blood pressure monitoring, Omron announced Thursday.
“High blood pressure is a growing concern in the United States among adults, and is often referred to as the ‘silent killer,’” stated Ranndy Kellogg, Omron Healthcare VP marketing and product development. “We’re thrilled to align with ‘America’s Doctor’ in the Sept. 7 season premier to help spread the word about the importance of home blood pressure monitoring, further helping to decrease the risk of heart disease and increase life expectancy.”
The Omron Healthcare integration includes a sponsored segment on "The Dr. Oz Show’s" premiere episode, in addition to a consumer incentive that will be revealed by Dr. Oz during the show. The first 50,000 visitors to DoctorOz.com will be able to download a $10 coupon good on any Omron Healthcare home blood pressure monitor at participating retailers.
The second season of "The Dr. Oz Show" will stress to viewers to “Know Your Five,” and blood pressure is one of those lifesaving numbers Americans need to know. As many as 1-in-3 people suffer from high blood pressure, according to the American Heart Association. And, research showed home blood pressure monitoring can be vital to reducing a patient’s risk of stroke, heart attack, heart failure or kidney failure.
Monitoring blood pressure at home is an important measure people can take to reduce their risk of a heart attack or stroke. More than 50% of people with high blood pressure who monitor at home show an improvement in medication compliance and are quicker to take action.
Bausch & Lomb kicks off Alaway ad campaign
MADISON, N.J. Bausch & Lomb on Wednesday launched its advertising campaign for Alaway, the 12-hour eye itch relief drops.
The campaign targets allergy sufferers using the slogan: “It’s not just your allergies, It’s your eyes.” The ads highlight that consumers don’t need to wait for systemic allergy medications to take effect before they can get relief for their itchy eyes.
The 15- and 30-second ads are airing during such shows as “America’s Got Talent,” “Law and Order” and “30 Rock.” They also aired during the recent “Miss Universe” and “Primetime Emmy Awards.” The Alaway commercials also are running on morning news and talk shows, game shows, soap operas and entertainment news productions.
The U.S. television ad campaign will run through September. The brand also will be supported in store with shelf talkers, feature ads, pharmacist displays, free-standing inserts and doctor detailing.
B&L developed the creative strategy with agencies Grey NY and Ionic Media.
Biodel’s VIAject gets name change
DANBURY, Conn. A specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes has changed the name of its lead product candidate.
Biodel said that the name Linjeta will replace the name of the company’s rapid-acting insulin formulation VIAject, which currently is under review by the Food and Drug Administration.
Errol De Souza, Biodel ‘s president and CEO, stated, “Today’s news reflects the continued progress of the Linjeta new drug application through FDA review and is an important milestone in our effort to commercialize this new drug candidate.”